resiquimod has been researched along with Condition, Preneoplastic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hengge, UR; Meykadeh, N | 1 |
Bichel, J; Lee, J; Meng, TC; Ortonne, JP; Stockfleth, E; Szeimies, RM | 1 |
1 trial(s) available for resiquimod and Condition, Preneoplastic
Article | Year |
---|---|
A phase II dose-ranging study of topical resiquimod to treat actinic keratosis.
Topics: Administration, Topical; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gels; Humans; Imidazoles; Keratosis; Male; Precancerous Conditions; Severity of Illness Index; Skin Neoplasms; Toll-Like Receptor 7; Treatment Outcome; Up-Regulation | 2008 |
1 other study(ies) available for resiquimod and Condition, Preneoplastic
Article | Year |
---|---|
[Topical immunomodulators in dermatology].
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Asthma; Autoimmune Diseases; Bowen's Disease; Child; Cyclopropanes; Dermatitis, Atopic; Dinitrochlorobenzene; Female; Follow-Up Studies; Herpes Simplex; Humans; Imidazoles; Imiquimod; Immunity, Cellular; Immunocompromised Host; Immunoglobulin A; Immunosuppressive Agents; Lichen Sclerosus et Atrophicus; Male; Molluscum Contagiosum; Papillomavirus Infections; Precancerous Conditions; Skin Diseases; Skin Diseases, Viral; Skin Neoplasms; Tacrolimus; Time Factors; Warts | 2003 |